Article | October 17, 2014

Q&A With Dr. John Harrison - Part 1: Current Problems In Alzheimer's Clinical Drug Trials

Source: CRF Health

By Heather Bilinski, Associate Director of Marketing, CRF Health

Q&A session with Dr. John Harrison

This is the beginning of a series of blog posts written following a Q&A session with Dr. John Harrison. During our conversation with Dr. Harrison we discussed the current problems with Alzheimer's Clinical Trials and the reasons behind the very low success rates for treatments. We then talked about some of the better instruments that can be used and how technology will help to turn the situation around in the future.